Syndax

Money

FDA Delays Decision on Syndax Leukemia Drug; Stock Sinks

Key Takeaways The Food and Drug Administration (FDA) delayed its approval for a leukemia drug from Syndax Pharmaceuticals after receiving…

Read More »
Back to top button